CELC Celcuity Inc. Stock Quote

CELC [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	32.70%	Shs Outstand	10.28M	Perf Week	-0.85%
Market Cap	326.96M	Forward P/E	-	EPS next Y	-1.97	Insider Trans	0.00%	Shs Float	5.04M	Perf Month	1.36%
Income	-9.50M	PEG	-	EPS next Q	-0.20	Inst Own	15.80%	Short Float	11.88%	Perf Quarter	62.40%
Sales	-	P/S	-	EPS this Y	-28.20%	Inst Trans	0.10%	Short Ratio	1.46	Perf Half Y	310.84%
Book/sh	1.14	P/B	23.61	EPS next Y	-93.10%	ROA	-60.20%	Target Price	30.00	Perf Year	438.20%
Cash/sh	-	P/C	-	EPS next 5Y	28.00%	ROE	-64.40%	52W Range	4.80 - 30.42	Perf YTD	193.78%
Dividend	-	P/FCF	-	EPS past 5Y	-30.80%	ROI	-	52W High	-11.53%	Beta	1.51
Dividend %	-	Quick Ratio	10.30	Sales past 5Y	-	Gross Margin	-	52W Low	461.21%	ATR	2.32
Employees	30	Current Ratio	10.30	Sales Q/Q	-	Oper. Margin	-	RSI (14)	57.59	Volatility	9.05% 8.00%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-40.60%	Profit Margin	-	Rel Volume	0.05	Prev Close	25.99
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	409.84K	Price	26.91
Recom	2.00	SMA20	1.47%	SMA50	32.65%	SMA200	127.93%	Volume	22,209	Change	3.54%

Jan-28-21

Reiterated

H.C. Wainwright

Buy

$14 → $18

Dec-24-20

Reiterated

H.C. Wainwright

Buy

$11 → $14

May-11-20

Resumed

Craig Hallum

Buy

Nov-20-18

Initiated

H.C. Wainwright

Buy

$36

May-10-21 04:00PM	Celcuity Inc. Reports First Quarter 2021 Financial Results and Provides Corporate Update ACCESSWIRE -7.26%
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Apr-26-21 05:00PM	Celcuity Inc. Schedules Release of First Quarter 2021 Financial Results and Webcast ACCESSWIRE +10.55%
Apr-23-21 09:35AM	Celcuity, Inc. (CELC) is on the Move, Here's Why the Trend Could be Sustainable Zacks
Apr-16-21 03:54PM	There Is More To Pfizer Than The Covid Vaccine InvestorPlace
Apr-15-21 08:58AM	Celcuity's (CELC) Shares March Higher, Can It Continue? Zacks
Apr-12-21 04:00PM	Celcuity Presents Data at AACR Annual Meeting Assessing Gedatolisib, a pan-PI3K/mTOR Inhibitor, in HER2-negative Breast and Ovarian Cancer Patient Tumors with Hyperactive RAS Network Signaling ACCESSWIRE +29.35%
09:37AM	Company News for Apr 12, 2021 Zacks
06:59AM	Celcuity (CELC) Soars on Agreement With Pfizer & Study Data Zacks
Apr-10-21 05:13AM	15 Best Stocks in the Past Week: Square, Roku, Pinterest TheStreet.com
Apr-09-21 04:30PM	How A Pfizer Cancer Drug Pact Launched Celcuity Stock Into A Breakout Investor's Business Daily +50.94%
06:37AM	Celcuity Stock Moves Higher After Licensing Pact With Pfizer For Gedatolisib In Breast Cancer Benzinga
Apr-08-21 04:05PM	Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update Business Wire
04:02PM	Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer Business Wire
Apr-06-21 02:41AM	We're Not Very Worried About Celcuity's (NASDAQ:CELC) Cash Burn Rate Simply Wall St.
Mar-18-21 08:38AM	Company News for Mar 18, 2021 Zacks +5.57%
Mar-17-21 07:43AM	The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes Benzinga +9.67%
Mar-16-21 04:00PM	Celcuity Announces Breast Cancer Clinical Trial Collaboration with MD Anderson, Novartis, and Puma Biotechnology to Study New Drug Regimen Business Wire
Mar-01-21 03:30PM	Celcuity Announces Closing of Common Stock Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock ACCESSWIRE
Feb-24-21 02:02PM	Celcuity Raises $24M Via Upsized Equity Offering At 11% Discount Benzinga -8.59%
07:30AM	Celcuity Prices Upsized Public Offering of Common Stock ACCESSWIRE
Feb-22-21 08:00AM	Celcuity Announces Proposed Public Offering of Common Stock ACCESSWIRE -6.74%
Feb-16-21 04:00PM	Celcuity Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights ACCESSWIRE
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Feb-01-21 01:00PM	Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2020 Financial Results and Conference Call ACCESSWIRE
Jan-28-21 08:03AM	The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga
Jan-27-21 05:31PM	Celcuity Announces Breast Cancer Clinical Trial Collaboration with Sarah Cannon and Pfizer to Study New Drug Regimen Business Wire
Jan-19-21 02:32PM	Celcuity to Present at the B. Riley Oncology Investor Conference Business Wire +11.03%
Jan-06-21 01:09AM	What Is The Ownership Structure Like For Celcuity Inc. (NASDAQ:CELC)? Simply Wall St.
Dec-23-20 07:00AM	Celcuity Announces Clinical Trial Collaboration with Massachusetts General Hospital and Puma Biotechnology ACCESSWIRE -8.05%
Nov-09-20 04:00PM	Celcuity Reports Third Quarter 2020 Financial Results and Recent Business Highlights ACCESSWIRE
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Oct-26-20 03:15PM	Celcuity Inc. Schedules Release of Third Quarter 2020 Financial Results and Conference Call ACCESSWIRE
Oct-04-20 09:30AM	Celcuity (NASDAQ:CELC) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
09:30AM	Celcuity (NASDAQ:CELC) Is In A Good Position To Deliver On Growth Plans CoinDesk
Aug-27-20 09:45AM	Celcuity to Present at the LD Micro 500 Investor Conference ACCESSWIRE
Aug-10-20 04:00PM	Celcuity Reports Second Quarter 2020 Financial Results and Recent Business Highlights ACCESSWIRE
Jul-24-20 04:45PM	Celcuity Inc. Schedules Release of Second Quarter 2020 Financial Results and Conference Call ACCESSWIRE
Jul-01-20 05:30PM	Celcuity Hosting Call on CELsignia Pathway Activity Test for Ovarian Cancer ACCESSWIRE
Jun-22-20 07:00PM	Celcuity Presents Data at AACR Annual Meeting for CELsignia Pathway Activity Test for Ovarian Cancer ACCESSWIRE +8.43%
May-07-20 04:00PM	Celcuity Reports First Quarter 2020 Financial Results and Recent Business Highlights ACCESSWIRE -5.00%
Apr-23-20 04:40PM	Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call ACCESSWIRE
Apr-07-20 09:23AM	Here's Why We're Not Too Worried About Celcuity's (NASDAQ:CELC) Cash Burn Situation Simply Wall St. -15.51%
Mar-12-20 04:00PM	Celcuity Reports Fourth Quarter and Full Year 2019 Financial Results ACCESSWIRE -5.48%
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Feb-27-20 04:15PM	Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call ACCESSWIRE
Dec-12-19 11:07AM	The Zacks Analyst Blog Highlights: Red Robin, Celcuity, Atlas Air and Boston Private Zacks
Dec-11-19 07:25PM	Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors ACCESSWIRE
08:34AM	4 Small Cap Stocks to Get Rid of Before Entering 2020 Zacks
Dec-05-19 10:24AM	Celcuity Announces Appointment of Richard Buller to Board of Directors Business Wire
Nov-07-19 04:01PM	Celcuity Reports Third Quarter 2019 Financial Results Business Wire
Nov-01-19 09:00AM	All You Need to Know About Celcuity, Inc. (CELC) Rating Upgrade to Buy Zacks
Oct-28-19 11:28AM	What Kind Of Investor Owns Most Of Celcuity Inc. (NASDAQ:CELC)? Simply Wall St.
Oct-24-19 03:31PM	Celcuity Inc. Schedules Release of Third Quarter 2019 Financial Results and Conference Call Business Wire
Sep-24-19 08:50AM	Paratek Pharmaceuticals (PRTK) Catches Eye: Stock Jumps 10.2% Zacks
Sep-11-19 11:37AM	Ultragenyx to Submit sBLA for Label Expansion of Crysvita Zacks
Sep-10-19 09:01AM	Adaptimmune (ADAP) Gets Orphan Drug Status for T-cell Therapy Zacks
07:59AM	Horizon's (HZNP) Eye Disease Drug Gets FDA's Priority Review Zacks
Sep-09-19 09:37AM	Celcuity Announces Appointment of Eric Lindquist as Chief Business Officer Business Wire
Aug-19-19 05:55PM	Nabriva (NBRV) Aims to Resubmit Contepo NDA in Q4 Zacks
09:00AM	Celcuity, Inc. (CELC) Upgraded to Strong Buy: Here's Why Zacks
Aug-08-19 04:00PM	Celcuity Reports Second Quarter 2019 Financial Results Business Wire
Jul-25-19 03:34PM	Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call Business Wire
Jun-27-19 09:00AM	What Makes Celcuity, Inc. (CELC) a New Strong Buy Stock Zacks +8.37%
May-20-19 02:36PM	Celcuity Announces Appointment of Leo Furcht to Board of Directors Business Wire
May-13-19 09:00AM	Celcuity, Inc. (CELC) Upgraded to Buy: What Does It Mean for the Stock? Zacks
May-07-19 04:01PM	Celcuity Reports First Quarter 2019 Financial Results Business Wire
02:30PM	Celcuity, Inc. to Host Earnings Call ACCESSWIRE
Apr-29-19 10:50AM	Introducing Celcuity (NASDAQ:CELC), A Stock That Climbed 15% In The Last Year Simply Wall St.
Apr-23-19 01:48PM	Celcuity Inc. Schedules Release of First Quarter 2019 Financial Results and Conference Call Business Wire
Apr-12-19 08:50AM	Autolus Therapeutics (AUTL) Catches Eye: Stock Jumps 5.6% Zacks
Apr-10-19 08:45AM	InflaRx (IFRX) Catches Eye: Stock Jumps 7.5% Zacks
Apr-04-19 08:33AM	Nabriva Therapeutics (NBRV) in Focus: Stock Moves 7.5% Higher Zacks
Mar-07-19 08:58AM	Krystal (KRYS) in Focus: Stock Moves 5.1% Higher Zacks
Mar-05-19 08:48AM	MyoKardia (MYOK) in Focus: Stock Moves 7.3% Higher Zacks -5.01%
Feb-26-19 09:20PM	Celcuity Inc. (CELC) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM	Celcuity Reports Fourth Quarter and Full Year 2018 Financial Results Business Wire
Feb-14-19 05:12PM	Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2018 Financial Results and Conference Call Business Wire
Dec-25-18 03:00PM	What Percentage Of Celcuity Inc. (NASDAQ:CELC) Shares Do Insiders Own? Simply Wall St.
Dec-11-18 08:10AM	Consolidated Research: 2018 Summary Expectations for IRHYTHM TECH, ON Semiconductor, CryoPort, Celcuity, InnerWorkings, and AgroFresh Solutions Fundamental Analysis, Key Performance Indications GlobeNewswire -8.88%
Dec-07-18 06:33PM	Celcuity Presents Results from Three Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and Co-Activated HER Family and c-Met Signaling Business Wire
Nov-13-18 04:00PM	Celcuity Reports Third Quarter 2018 Financial Results Business Wire
Oct-31-18 08:00AM	HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President GlobeNewswire
Oct-30-18 04:56PM	Celcuity Inc. Schedules Release of Third Quarter 2018 Financial Results and Conference Call Business Wire
Oct-19-18 07:45AM	Detailed Research: Economic Perspectives on BeiGene, Costco Wholesale, Rogers, Advance Auto Parts, Celcuity, and Harris What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-16-18 05:51PM	Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center Business Wire
Aug-09-18 04:00PM	Celcuity Reports Second Quarter 2018 Financial Results Business Wire
02:30PM	Celcuity Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 04:31PM	Celcuity Inc. Schedules Release of Second Quarter 2018 Financial Results and Conference Call Business Wire
May-14-18 04:00PM	Celcuity Reports First Quarter 2018 Financial Results Business Wire
May-02-18 12:28PM	Celcuity Inc. Schedules Release of First Quarter 2018 Financial Results and Conference Call Business Wire
Mar-19-18 07:33AM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Celcuity Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Mar-15-18 04:00PM	Celcuity Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
Mar-02-18 04:00PM	Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2017 Financial Results and Conference Call Business Wire
Jan-19-18 07:30AM	Investor Expectations to Drive Momentum within Advanced Micro Devices, Knoll, Hubbell, Celcuity, SecureWorks, and First Foundation Discovering Underlying Factors of Influence GlobeNewswire
Nov-13-17 07:00AM	Celcuity Reports Third Quarter Fiscal 2017 Financial Results Business Wire
Nov-02-17 01:08PM	Celcuity Inc. Schedules Release of Third Quarter Fiscal 2017 Financial Results and Conference Call Business Wire
Oct-31-17 09:15PM	Is Celcuity Incs (CELC) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Sep-24-17 09:57AM	IPO News This Week: Roku, PQ Group Lead 7 Offerings Due Out 24/7 Wall St.
Sep-22-17 04:05PM	Celcuity Announces Closing of Initial Public Offering Business Wire

Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience